P1.13-05 Integrin Β3 Inhibition Enhances the Antitumor Activity of Alk Inhibitor in Alkrearranged NSCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.862
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P1.13-04 Integrin Β3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK Rearranged NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P1.13-44 Safety, PK, and Preliminary Antitumor Activity of the Oral EGFR/HER2 Exon 20 Inhibitor TAK-788 in NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

RAF Dimer Inhibition Enhances the Antitumor Activity of MEK Inhibitors in K‐RAS Mutant Tumors

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2020English

P1.13-07 Epithelial-Mesenchymal Transition Induced the Acquired Resistance to ALK Inhibitor Brigatinib in Lung Cancer Cells Harboring With ALK Fusions

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Antitumor Activity of Selective MEK1/2 Inhibitor AZD6244 in Combination With PI3K/mTOR Inhibitor BEZ235 in Gefitinib-Resistant NSCLC Xenograft Models

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2014English

Protein Kinase a Inhibition Facilitates the Antitumor Activity of Xanthohumol, a Valosin-Containing Protein Inhibitor

Cancer Science
Cancer ResearchMedicineOncology
2017English

The Novel ATM Inhibitor (AZ31) Enhances Antitumor Activity in Patient Derived Xenografts That Are Resistant to Irinotecan Monotherapy

Oncotarget
Oncology
2017English

OA02.02 Safety and Preliminary Clinical Activity of Ropotrectinib (TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Epigenetic Silencing of miR-483-3p Promotes Acquired Gefitinib Resistance and EMT in EGFR-mutant NSCLC by Targeting Integrin Β3

Oncogene
Cancer ResearchGeneticsMolecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy